International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Clopidogrel Tablets USP, 75 mg packaged in bottles of 30 tablets Due to Mislabeling NDC # 54458-888-16; Lot # 117099A

International Laboratories, LLC is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Clopidogrel tablets USP 75 mg but may contain Clopidogrel 75mg or Simvastatin Tablets USP 10 mg.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news

Related Links:

STATINS can cause a number of side effects in some people, like many medications do. Nonetheless, some are more uncommon than others and can be troublesome. There are some signs to look out for which should be immediately checked with a doctor.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
This article is protected by copyright. All rights reserved.PMID:34562277 | DOI:10.1002/jcph.1973
Source: The Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research
Dual antiplatelet therapy after PCI, statin side effects, nightshift work and AF, and a cautionary note regarding therapeutic enthusiasm in HF care are the topics John Mandrola, MD, discusses in this week ’s podcast.theheart.org on Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Commentary Source Type: news
Expert Opin Investig Drugs. 2021 Sep 24. doi: 10.1080/13543784.2021.1985463. Online ahead of print.ABSTRACTINTRODUCTION: Recent years have witnessed unprecedented progress in stroke care, but unmet needs persist regarding the efficacy of acute treatment and secondary prevention. Novel approaches are being tested to enhance the efficacy of thrombolysis or provide neuroprotection in non-thrombolized patients.AREAS COVERED: The current review highlights pharmaceutical agents under evaluation in clinical trials concerning the acute, subacute, and chronic phase post-stroke. We examine the evidence in favor of tenecteplase as an...
Source: Expert Opinion on Investigational Drugs - Category: Drugs & Pharmacology Authors: Source Type: research
Curr Med Res Opin. 2021 Sep 24:1. doi: 10.1080/03007995.2021.1984222. Online ahead of print.ABSTRACTOBJECTIVE: To investigate whether statin adherence (defined as proportion days covered, PDC) is associated with LDL-c response in statin initiators on standard and low starting-dose of statins, and to detect a possible interaction with sex.METHODS: An inception cohort study was conducted using the PharmLines Initiative, a linkage between the Lifelines Cohort Study and University of Groningen's IAD.nl (prescription database). First-time statin users were followed from baseline to follow-up measurement. We matched participants...
Source: Current Medical Research and Opinion - Category: Research Authors: Source Type: research
Expert Opin Investig Drugs. 2021 Sep 24. doi: 10.1080/13543784.2021.1985463. Online ahead of print.ABSTRACTINTRODUCTION: Recent years have witnessed unprecedented progress in stroke care, but unmet needs persist regarding the efficacy of acute treatment and secondary prevention. Novel approaches are being tested to enhance the efficacy of thrombolysis or provide neuroprotection in non-thrombolized patients.AREAS COVERED: The current review highlights pharmaceutical agents under evaluation in clinical trials concerning the acute, subacute, and chronic phase post-stroke. We examine the evidence in favor of tenecteplase as an...
Source: Expert Opinion on Investigational Drugs - Category: Drugs & Pharmacology Authors: Source Type: research
Curr Med Res Opin. 2021 Sep 24:1. doi: 10.1080/03007995.2021.1984222. Online ahead of print.ABSTRACTOBJECTIVE: To investigate whether statin adherence (defined as proportion days covered, PDC) is associated with LDL-c response in statin initiators on standard and low starting-dose of statins, and to detect a possible interaction with sex.METHODS: An inception cohort study was conducted using the PharmLines Initiative, a linkage between the Lifelines Cohort Study and University of Groningen's IAD.nl (prescription database). First-time statin users were followed from baseline to follow-up measurement. We matched participants...
Source: Current Medical Research and Opinion - Category: Research Authors: Source Type: research
Evid Based Complement Alternat Med. 2021 Sep 13;2021:2280440. doi: 10.1155/2021/2280440. eCollection 2021.ABSTRACTColorectal cancer (CRC) is one of the most common malignant tumors with high morbidity and mortality. The early symptoms are latent, and most patients are in the middle or late stage when they are diagnosed. The best opportunity for surgery has been lost, and surgical resection has failed to achieve good results. In clinical practice, targeted therapy or chemotherapy is usually the main treatment. The mFOLFOX6 regimen is a standardized regimen for the treatment of advanced CRC. The main drugs in this regimen ar...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Authors: Source Type: research
A new study sheds light on the question of whether statin therapy negatively impacts memory and cognition.Journal of the American College of Cardiology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Nasal delivery has been indicated as one of the most interesting alternative routes for the brain delivery of neuroprotective drugs. Nanocarriers have emerged as a promising strategy for the delivery of neurotherapeutics across the nasal epithelia. In this work, hybrid lecithin/chitosan nanoparticles (LCNs) were proposed as a drug delivery platform for the nasal administration of simvastatin (SVT) for the treatment of neuroinflammatory diseases. The impact of SVT nanoencapsulation on its transport across the nasal epithelium was investigated, as well as the efficacy of SVT-LCNs in suppressing cytokines release in a cellula...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Clopidogrel | Drugs & Pharmacology | Plavix | Simvastatin | Statin Therapy | Zocor